» Articles » PMID: 37138086

Glioblastoma Remodelling of Human Neural Circuits Decreases Survival

Abstract

Gliomas synaptically integrate into neural circuits. Previous research has demonstrated bidirectional interactions between neurons and glioma cells, with neuronal activity driving glioma growth and gliomas increasing neuronal excitability. Here we sought to determine how glioma-induced neuronal changes influence neural circuits underlying cognition and whether these interactions influence patient survival. Using intracranial brain recordings during lexical retrieval language tasks in awake humans together with site-specific tumour tissue biopsies and cell biology experiments, we find that gliomas remodel functional neural circuitry such that task-relevant neural responses activate tumour-infiltrated cortex well beyond the cortical regions that are normally recruited in the healthy brain. Site-directed biopsies from regions within the tumour that exhibit high functional connectivity between the tumour and the rest of the brain are enriched for a glioblastoma subpopulation that exhibits a distinct synaptogenic and neuronotrophic phenotype. Tumour cells from functionally connected regions secrete the synaptogenic factor thrombospondin-1, which contributes to the differential neuron-glioma interactions observed in functionally connected tumour regions compared with tumour regions with less functional connectivity. Pharmacological inhibition of thrombospondin-1 using the FDA-approved drug gabapentin decreases glioblastoma proliferation. The degree of functional connectivity between glioblastoma and the normal brain negatively affects both patient survival and performance in language tasks. These data demonstrate that high-grade gliomas functionally remodel neural circuits in the human brain, which both promotes tumour progression and impairs cognition.

Citing Articles

Microenvironmental Drivers of Glioma Progression.

Jang H, Park J Int J Mol Sci. 2025; 26(5).

PMID: 40076738 PMC: 11900340. DOI: 10.3390/ijms26052108.


ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study.

Slattery K, Kauss M, Raval D, Hsieh E, Choi A, Davis T Neurooncol Adv. 2025; 7(1):vdaf002.

PMID: 40041201 PMC: 11879401. DOI: 10.1093/noajnl/vdaf002.


Tumor resting-state fMRI connectivity to extralesional brain is associated with cognitive performance in glioma patients.

Na C, Clusmann H, Wiesmann M, Jutten K, Mainz V Brain Spine. 2025; 5:104202.

PMID: 40007801 PMC: 11851226. DOI: 10.1016/j.bas.2025.104202.


Neuropathic Pain Following Surgery for Malignant Peripheral Nerve Sheath Tumors.

Raasveld F, Hanna T, Pacheco F, Gonzalez M, Johnston B, Lozano-Calderon S Ann Surg Oncol. 2025; .

PMID: 39987385 DOI: 10.1245/s10434-025-17001-9.


GABAergic neuron-to-glioma synapses in diffuse midline gliomas.

Barron T, Yalcin B, Su M, Byun Y, Gavish A, Shamardani K Nature. 2025; .

PMID: 39972132 DOI: 10.1038/s41586-024-08579-3.


References
1.
Venkataramani V, Tanev D, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T . Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature. 2019; 573(7775):532-538. DOI: 10.1038/s41586-019-1564-x. View

2.
Venkatesh H, Morishita W, Geraghty A, Silverbush D, Gillespie S, Arzt M . Electrical and synaptic integration of glioma into neural circuits. Nature. 2019; 573(7775):539-545. PMC: 7038898. DOI: 10.1038/s41586-019-1563-y. View

3.
Venkatesh H, Johung T, Caretti V, Noll A, Tang Y, Nagaraja S . Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion. Cell. 2015; 161(4):803-16. PMC: 4447122. DOI: 10.1016/j.cell.2015.04.012. View

4.
Venkatesh H, Tam L, Woo P, Lennon J, Nagaraja S, Gillespie S . Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature. 2017; 549(7673):533-537. PMC: 5891832. DOI: 10.1038/nature24014. View

5.
Buckingham S, Campbell S, Haas B, Montana V, Robel S, Ogunrinu T . Glutamate release by primary brain tumors induces epileptic activity. Nat Med. 2011; 17(10):1269-74. PMC: 3192231. DOI: 10.1038/nm.2453. View